Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group.
Saved in:
| Title: | Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group. |
|---|---|
| Authors: | Papageorgiou, Sotirios G. sotirispapageorgiou@hotmail.com, Kotsianidis, Ioannis1,2, Kontos, Christos K., Symeonidis, Argyris2,3, Galanopoulos, Athanasios2,4, Hatzimichael, Eleftheria, Poulakidas, Elias, Diamantopoulos, Panagiotis, Vassilakopoulos, Theodoros P., Zikos, Panagiotis, Papadaki, Helen, Bouronikou, Eleni, Panayiotidis, Panayiotis, Viniou, Nora-Athina2,5, Pappa, Vasiliki2,6 |
| Source: | Leukemia Research. Aug2018, Vol. 71, p55-59. 5p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
